Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy

Sun, 27th Dec 2020 12:39

(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph

Footfall at the Boxing Day sales was down by more than half on last year as non-essential retail remained closed in much of the country under tightened coronavirus restrictions. While queues were seen outside shops in areas under tiers 2 and 3, high streets in the 43% of England that is under tier 4 were empty. The retail intelligence agency Springboard said Boxing Day footfall in the UK up to 10am was down 57% compared with last year. - Guardian

Britain's economy will outperform European rivals such as France over the next 15 years, according to morale-boosting forecasts published in the wake of the Government's Brexit trade deal with Brussels. A new ranking shows the UK remaining the world's 5th biggest economy next year. From 2025 it slips one place, but still performs better than many peer western economies. The UK's economy will be 23pc larger than that of France by 2035, the Centre for Economics and Business Research (CEBR) predicts. - Sunday Telegraph

The car industry is in a race against time to build giant battery gigafactories in the UK to ensure its survival and avoid damaging tariffs from the Brexit trade deal. Details of the EU deal revealed that Britain has a six-year window to build its supply of electric vehicle parts - either domestically or from the Continent - if it wants to continue selling them tariff-free to Europe. - Sunday Times

Bankers are gearing up for a surge of flotations on the London Stock Exchange next year as companies that delayed listing their shares due to the pandemic press ahead with plans to tap public markets. Dealmakers said they expect a boom in initial public offerings (IPOs) driven by pent up demand after pandemic disruption effectively halted new listings for much of 2020. Advisers predicted increased investor appetite for tech and healthcare firms that have done well in the crisis. - Sunday Telegraph

More than three-quarters of MPs are expected to dial in remotely to a debate that will consider the government's Brexit deal on Wednesday. The majority of MPs are preparing to participate online after the Commons speaker urged them to stay at home and made it clear those present in person will not be given priority to speak. Both the Commons and the Lords will sit for a single day on December 30 to pass the Future Relationship Bill implementing the government's free trade deal with the EU. - Sunday Times

Industry figures are calling on EU leaders to urgently agree a Brexit "adjustment period" after negotiators left them with just three working days to prepare for the end of the Brexit transition period. While big business including manufacturers and supermarkets have made Brexit preparations costing hundreds of millions of pounds, they say there is not enough time over Christmas to implement the newly agreed trading regime. - Guardian

The Bank of England could pull the trigger on negative interest rates if strict coronavirus restrictions are extended well into the new year, leading economists have warned. Interest rates are at record lows of 0.1%, leaving rate-setters with little room to move and raising the prospect of negative rates in the UK for the first time. - Sunday Times

City veteran Keith Skeoch has been appointed by the Treasury to lead a review of banking regulations in what could be the biggest overhaul of the sector since the fallout of the financial crisis a decade ago. The former chief executive of Standard Life Aberdeen will revisit the stringent rules put in place to rein in banks after several were bailed out by the Government in 2008, including Royal Bank of Scotland, Lloyds TSB and HBOS. - Financial Mail on Sunday
More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.